Mike Clark

Cited by

	All	Since 2019
Citations	12525	2465
h-index	46	22
i10-index	87	38

520

260

130

390

198519861987198819891990199119921993199419951996199719981999200020012002200320042005200620072008200920102011201220132014201520162017201820192020202120222023202442 37 52 114 150 228 246 292 305 279 258 178 212 214 204 219 280 273 248 244 295 294 329 429 405 435 429 475 470 483 474 421 462 421 506 514 479 378 343 245

Public access

View all

8 articles

0 articles

available

not available

Based on funding mandates

Co-authors

HERMAN WALDMANNoxford universityVerified email at path.ox.ac.uk
Kathryn ArmourPrincipal Scientist, LifeArc, Stevenage, UKVerified email at lifearc.org
Stephen CobboldEmeritus Professor of Cellular Immunology, Sir William Dunn School of Pathology, University ofVerified email at path.ox.ac.uk
MJS DyerErnest and Helen Scott Haematological Research Institute, University of LeicesterVerified email at leicester.ac.uk
Professor Willem H. OuwehandDept of Haematology, University of CambridgeVerified email at cam.ac.uk
Suzanne WattnhsbtVerified email at nhsbt.nhs.uk
Helen TigheCell IDxVerified email at cellidx.com
robert marcusConsultant Haematologist HCA Health careVerified email at theloc.com
Professor Peter J. FriendProfessor of Transplantation, University of OxfordVerified email at nds.ox.ac.uk
Inger sandlieVerified email at ibv.uio.no
Jalkanen SImmunologian professori, Turun yliopistoVerified email at utu.fi
Pietro MastroeniProfessor of Infection and Immunity, University of CambridgeVerified email at cam.ac.uk
Dr Andrew GrantAssociate Professor in Microbial Pathogenesis, University of CambridgeVerified email at cam.ac.uk
Yun Shan GohA*STAR ID labsVerified email at idlabs.a-star.edu.sg
William SandbornUniversity of California San DiegoVerified email at ucsd.edu
Michael KammUniversity of MelbourneVerified email at unimelb.edu.au
Bruce E. SandsIcahn School of Medicine at Mount SinaiVerified email at mssm.edu
Stefan SchreiberKielVerified email at mucosa.de
Amir M GhaemmaghamiUniversity of NottinghamVerified email at nottingham.ac.uk
Olivier RestifAssociate Professor in Epidemiology, Department of Veterinary Medicine, University of CambridgeVerified email at cam.ac.uk

Mike Clark

Retired (30th Sept 2014) as Reader in Therapeutic and Molecular Immunology, Cambridge University

Verified email at cam.ac.uk - Homepage

Immunology biotechnology immunotherapy antibody therapeutics antibodies


Title Sort by citations Sort by year Sort by title	Cited by Cited by	Year
Reshaping human antibodies for therapy L Riechmann, M Clark, H Waldmann, G Winter Nature 332 (6162), 323-327, 1988	3641	1988
Comparison of the effector functions of human immunoglobulins using a matched set of chimeric antibodies. M Brüggemann, GT Williams, CI Bindon, MR Clark, MR Walker, R Jefferis, ... The Journal of experimental medicine 166 (5), 1351, 1987	1113	1987
Remission induction in non-Hodgkin lymphoma with reshaped human monoclonal antibody CAMPATH-1H G Hale, MR Clark, R Marcus, G Winter, MJS Dyer, JM Phillips, ... The Lancet 332 (8625), 1394-1399, 1988	734	1988
Recombinant human IgG molecules lacking Fc receptor I binding and monocyte triggering activities KL Armour, MR Clark, AG Hadley, LM Williamson European journal of immunology 29, 2613-2624, 1999	542	1999
Antibody humanization: a case of the "Emperor's new clothes"? M Clark Immunology today 21 (8), 397-402, 2000	470	2000
IgG Effector Functions MR Clark Chemical immunology 65, 88-110, 1997	343*	1997
The generation of a humanized, non‐mitogenic CD3 monoclonal antibody which retains in vitro immunosuppressive properties S Bolt, E Routledge, I Lloyd, L Chatenoud, H Pope, SD Gorman, M Clark, ... European journal of immunology 23 (2), 403-411, 1993	319	1993
American gastroenterological association consensus development conference on the use of biologics in the treatment of inflammatory bowel disease, June 21-23, 2006 M Clark, JF Colombel, BC Feagan, RN Fedorak, SB Hanauer, MA Kamm, ... Gastroenterology 133 (1), 312-339, 2007	307	2007
Monoclonal-antibody therapy in systemic vasculitis PW Mathieson, SP Cobbold, G Hale, MR Clark, DBG Oliveira, ... New England Journal of Medicine 323 (4), 250-254, 1990	300	1990
Reshaping a therapeutic CD4 antibody SD Gorman, MR Clark, EG Routledge, SP Cobbold, H Waldmann Proceedings of the National Academy of Sciences 88 (10), 4181, 1991	245	1991
Humanized anti-CD3 specific antibodies SL Bolt, MR Clark, SD Gorman, EG Routledge, H Waldmann, ... US Patent 6,706,265, 2004	233*	2004
Structural motifs involved in human IgG antibody effector functions J Greenwood, M Clark, H Waldmann European journal of immunology 23 (5), 1098-1104, 1993	215	1993
Tolerance to rat monoclonal antibodies. Implications for serotherapy. RJ Benjamin, SP Cobbold, MR Clark, H Waldmann The Journal of experimental medicine 163 (6), 1539-1552, 1986	215	1986
Humanized anti-CD3 specific antibodies SL Bolt, MR Clark, SD Gorman, EG Routledge, H Waldman US Patent App. 11/300,396, 2005	202*	2005
Humanized anti-CD3 specific antibodies SL Bolt, MR Clark, SD Gorman, EG Routledge, H Waldmann US Patent 5,585,097, 1996	202	1996
Humanized anti-CD3 specific antibodies SL Bolt, MR Clark, SD Gorman, EG Routledge, H Waldman US Patent App. 11/501,894, 2006	199*	2006
Humanized anti-CD3 specific antibodies SL Bolt, MR Clark, SD Gorman, EG Routledge, H Waldman US Patent App. 10/743,423, 2003	196*	2003
Humanized anti-CD3 specific antibodies S Bolt, M Clark, S Gorman, E Routledge, H Waldman US Patent App. 11/300,278, 2005	195*	2005
Humanized anti-CD3 specific antibodies SL Bolt, MR Clark, SD Gorman, EG Routledge, H Waldman US Patent App. 11/300,279, 2005	195*	2005
Differential binding to human FcγRIIa and FcγRIIb receptors by human IgG wildtype and mutant antibodies KL Armour, JGJ van de Winkel, LM Williamson, MR Clark Molecular immunology 40 (9), 585-593, 2003	184	2003

The system can't perform the operation now. Try again later.

Articles 1–20

Citations per year

Duplicate citations

Merged citations

Add co-authorsCo-authors

Follow

Cited by

Co-authors